Veru's experimental drug helps older obese patients on Wegovy preserve muscle
Veru said on Monday its experimental drug in combination with Novo Nordisk's weight-loss treatment Wegovy, helped preserve muscle in older patients with obesity, meeting the main goal of a mid-stage ...
Hosted on MSN17m
NVO Stock Rises as New Obesity Drug Shows Superior Weight Loss
Shares of Novo Nordisk NVO gained 8.5% on Friday after the company announced positive top-line data from an early to ...
ENDPOINTS NEWS29m
Veru's drug lessens loss of lean mass in pa­tients tak­ing We­govy
Veru says its muscle-maintaining drug preserved more lean mass in older patients taking a GLP-1, but skittish investors ...